Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus.
Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Older people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness.
The best way to prevent and slow down transmission is be well informed about the COVID-19 virus, the disease it causes and how it spreads. Protect yourself and others from infection by washing your hands or using an alcohol based rub frequently and not touching your face.
The COVID-19 virus spreads primarily through droplets of saliva or discharge from the nose when an infected person coughs or sneezes, so it’s important that you also practice respiratory etiquette (for example, by coughing into a flexed elbow).
At this time, there are no specific vaccines or treatments for COVID-19. However, there are many ongoing clinical trials evaluating potential treatments. WHO will continue to provide updated information as soon as clinical findings become available.
- Protect yourself: advice for the public
- Myth busters
- Questions and answers
- Situation reports
- All information on the COVID-19 outbreak
WHO – World Health Organisation
- WHO issues its first emergency use validation for a COVID-19 vaccine and emphasizes need for equitable global accessThe World Health Organization (WHO) today listed the Comirnaty, COVID-19 mRNA vaccine for emergency use, making the Pfizer/BioNTech vaccine the first to receive emergency validation from WHO since the outbreak began a year ago.
- In his end of year message for 2020, WHO Director-General says there is light at the end of the tunnel in the fight against COVID-19. But going into 2021, he urges countries and communities to work together, in solidarity, to overcome this and future health challenges.
- Since the global youth movement, 1+1 youth Initiative was launched on World TB Day 2019, followed by the adoption of the Youth Declaration to End TB at the first-ever Global Youth Townhall on ending TB, there has been significant progress over the past year. The 1+1 Initiative has expanded to include thousands of youth across the world […]
- The Behavioural Insights Unit of the WHO released a meeting report of the Technical Advisory Group (TAG) on the special session on acceptance and uptake of COVID-19 vaccines, held on 15 October 2020. The meeting report outlines the factors that drive people’s behaviour in relation to vaccine acceptance and uptake: an enabling environment, social influences […]
- Joint statement calling for urgent country scale-up of access to optimal HIV treatment for infants and children living with HIVGlobal partners that are committed to ending paediatric AIDS have come together to call on countries to rapidly scale up access to optimal, child-friendly HIV treatment for infants and children.
ECDC – European Centre for Disease Prevention and Control
- Weekly epidemiological update: Omicron variant of concern (VOC) – week 2 (data as of 20 January 2022) EU/EEAAs of 20 January 2022, the Omicron variant has been identified in all EU/EEA countries. From 20 December 2021 to 9 January 2022, there were 23 EU/EEA countries with adequate sequencing volume that reported an estimated prevalence of Omicron VOC of 69.4%.
- Weekly epidemiological update: Omicron variant of concern (VOC) – week 2 (data as of 13 January 2022) EU/EEAFrom 20 December 2021 to 2 January 2022, there were 21 EU/EEA countries with adequate sequencing volume that reported an estimated prevalence of Omicron VOC of 46%.
- Weekly epidemiological update: Omicron variant of concern (VOC) – week 1 (data as of 7 January 2022) EU/EEAOver the past two weeks, a steep increase in COVID-19 notification rates has been observed in several EU/EEA countries.
- Weekly epidemiological update: Omicron variant of concern (VOC) – week 50 (data as of 19 December 2021)As of 19 December and since 16 December 2021, 1 533 additional SARS-CoV-2 Omicron variant of concern (VOC) cases have been confirmed in the European Union and European Economic Area (EU/EEA), contributing to an overall total of 4 691 confirmed cases so far. Countries and territories outside of the EU/EEA have reported 30 220 confirmed […]
- As of 16 December and since 15 December 2021, 529 additional SARS-CoV-2 Omicron variant of concern (VOC) cases have been confirmed in the European Union and European Economic Area (EU/EEA), contributing to an overall total of 3 158 confirmed cases so far.